AKT1 and hepatocellular carcinoma: Aberrant expression of Lnc-Myd88 increased Myd88 levels, resulting in the activation of both NF-κB and PI3K/AKT signal pathways and then promoting the proliferation and metastasis of HCC both in vitro and in vivo.